Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hua Medicine ( (HK:2552) ) has provided an update.
Hua Medicine has announced that its board of directors will meet on August 28, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will determine the company’s financial performance and potentially impact its market positioning and stakeholder confidence.
More about Hua Medicine
Hua Medicine is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on developing innovative therapies and is publicly listed on the Hong Kong Stock Exchange.
YTD Price Performance: 139.04%
Average Trading Volume: 9,966,170
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.39B
See more data about 2552 stock on TipRanks’ Stock Analysis page.